Skip to main content
. 2021 Jul 21;11:677826. doi: 10.3389/fonc.2021.677826

Figure 6.

Figure 6

RBM10 deficiency is associated with many immune markers. (A, B) Quantitative analysis of mRNA expression of immune checkpoint molecules of between RBM10 deficient LUADs and those with normal expression in TCGA_LUAD (A) and CHOICE_ADC (B) cohorts. (C, D) Several predicted TIDE scores are dysregulated in RBM10 deficient LUADs in both TCGA_LUAD (C) and CHOICE_ADC (D) cohorts. (E) The impacts of RBM10 expression on the effect of cytotoxic T lymphocytes based on survival data of a Japanese LAUD cohort from online website of TIDE.